Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
|
|
Associated Press (12.19.01) - Wednesday, December 19, 2001
Kim Curtis
Cyclists from all over the country have joined the annual ride from San Francisco to Los Angeles, a grueling, one-week, 575- mile trek down Highway 1. But the San Francisco AIDS Foundation and the Los Angeles Gay and Lesbian Center say Pallotta Teamworks, the ride's organizer for the past eight years, has mismanaged the event and increased its overhead so much that they're better off running it themselves. So next summer, they're planning their own competing six-day fundraising ride, dubbed AIDS/LifeCycle, along the same route, two weeks before the traditional AIDS Ride. In response, Pallotta Teamworks is suing the non-profits and has found a new charity for the AIDS ride.
The California AIDS Ride provides about a quarter of the San Francisco AIDS Foundation's $24 million annual operating budget, according to spokesperson Gustavo Suarez. "This year they raised more money than ever before, and we got back a lower percentage," he said. In 2000, the foundation received 65 cents of every dollar, according to the Better Business Bureau's Wise Giving Alliance.
"We've raised over $40 million in California since 1994 for people living with HIV and AIDS," said Pallotta spokesperson Norm Bowling. "Now the prospect of two competing events is just going to divide the community... and will affect everyone ultimately by having less funds raised." Bowling acknowledged that Pallotta ran 8-9 percent over budget overall this year, but he said the AIDS Ride has a "great track record" and that the charities are overstepping their bounds.
011219
AD012197
Copyright © 2001 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.